retatrutide nonalcoholic steatohepatitis trial fatty liver disease nash Retatrutide, the triple G, Glucagon-GIP-GLP-1 based triagonist produces substantial resolution of liver fat #NAFLD in PPL with #obesity #ADA2023 @ADA_DiabetesPro @AmDiabetesAssn #NASH trial coming Retatrutide vs Survodutide: 24% vs

Ali says this is simply good news for people with type 2 diabetes, overweight, or obesity who also have depression or anxiety

What to consider if your results are out of range: If you're low in folate, increase your intake of naturally folate-rich foods such as spinach and other dark greens, asparagus, Brussels sprouts, avocado, black-eyed peas and other legumes, and citrus fruits

The Participant Center: U24 OD023176

Highmark April 2026 Formulary Overview: Prescription Drug Management Updates Please see key updates from Highmarks April 2026 Formulary Overview and recent prescription drug management changes

Your body produces it naturally, but levels can decline due to age, environmental stressors, and poor diet